United States Of America V. Sealed Defendant 1 Et Al

Case Background

The United States and the Plaintiff States (the United States and the Plaintiff States are collectively referred to herein as the “Government”) through their qui tam Relator Patricia Frattasio, sued Biohaven Pharmaceuticals, Inc. and its holding company, Biohaven Pharmaceuticals Holding Company, Ltd. under the False Claims Act, 31 U.S.C. § 3729 et seq. They sought damages, penalties, and other remedies under federal and state false claims laws. Whistleblower Patricia Frattasio accused Biohaven of submitting fraudulent claims for payment to Medicare, Medicaid, TRICARE, and VA. The claims allegedly violated the Anti-Kickback Statute. Frattasio claimed that Biohaven offered financial incentives to healthcare providers, such as speaking fees and meals, to encourage them to prescribe Nurtec ODT to federal healthcare beneficiaries. The lawsuit was filed in the United States District Court for the Western District of New York (Rochester). Honorable Charles J. Siragusa presided over the case [Case Number: 6:21cv6539].

Cause